[144] Honeywell International, Inc. SEC Filing
Rhea-AI Filing Summary
Honeywell International (HON) Form 144 filing discloses a planned sale of 3,448 common shares through Morgan Stanley Smith Barney on or about 01 Aug 2025. Based on the filer’s reference price, the transaction is valued at $752,026. The shares originate from recent restricted-stock vesting and option exercises under Honeywell’s equity-compensation plans. With 634.9 million shares outstanding, the proposed sale equals roughly 0.0005 % of total shares.
No sales have been reported in the past three months, and the signer certifies possession of no undisclosed adverse information, as required by Rule 144. Because Form 144 only signals intent, the sale may or may not be executed. Given the modest size relative to Honeywell’s float and average trading volumes, the filing appears to be routine insider activity with limited market impact.
Positive
- None.
Negative
- None.
Insights
TL;DR: Minor $0.75 M insider sale—immaterial to Honeywell’s valuation or liquidity.
The filing covers 3,448 shares, equating to roughly half of one basis point of HON’s float. Sourced entirely from option exercises and restricted-stock vesting, the sale looks like standard diversification rather than a signal on fundamentals. No accompanying negative disclosures or clustered insider selling patterns are evident. Liquidity impact is negligible, and the amount is trivial versus Honeywell’s daily dollar volume, so I view this as neutral for investors.
TL;DR: Filing demonstrates routine Rule 144 compliance; governance risk minimal.
The notice satisfies statutory requirements, confirming the insider is unaware of undisclosed material information and that shares stem from registered plans. Absence of past-three-month sales suggests no aggressive liquidation trend. From a governance lens, adherence to Rule 144 and use of a major broker support sound controls. Market should interpret this as ordinary-course activity with no material governance red flags.